FDA Approved: SYPRINE — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental application for SYPRINE (trientine hydrochloride) submitted by Bausch Health US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Drugs mentioned

• SYPRINE (trientine hydrochloride)

Snippet

SUPPL AP for SYPRINE (TRIENTINE HYDROCHLORIDE)